Full name
CARDIOCARE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Other research and experimental development on natural sciences and engineering
46.1 - Wholesale on a fee or contract basis
47.1 - Retail sale in non-specialised stores
68.20.Z - Rental and operating of own or leased real estate
71.20.A - Food quality testing and analysis
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
75.00.Z - Veterinary activities
86.10.Z - Hospital activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -1,5 | -0,2 | -0 | 86 |
EBITDA | -1,5 | -0,2 | -0 | 86 |
Short time liabilities | 0 | 0,1 | 0,3 | 145 |
Equity capital | -22,6 | -22,8 | -22,9 | -0,1 |
Operating profit (EBIT) | -1,5 | -0,2 | -0 | 86 |
Assets | 2 | 1,9 | 2 | 8 |
Net profit (loss) | -1,5 | -0,2 | -0 | 86 |
Cash | 2 | 1,9 | 2 | 8 |
Net income from sale | 0 | 0 | 0,2 | -∞ |
Liabilities and provisions for liabilities | 24,6 | 24,7 | 24,9 | 0,7 |
Working assets | 2 | 1,9 | 2 | 8 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 6,5 | 0,9 | 0,1 | -0,8 |
Equity capital to total assets | -1152 | -1209,7 | -1121,9 | 87,8 |
Gross profit margin | -14 | 134 | ||
EBITDA Margin | -14 | 134 | ||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 0 | 2 147 483 648 | 550 | -2 147 483 098 |
Current financial liquidity indicator | 15.34691047668457 | 6.763923168182373 | -8,5 | |
Net dept to EBITDA | -15.335433006286621 | -113.43120574951172 | -805.7867431640625 | -692,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane